I don't think CR is necessary in the short term, although given the nature of the facility in place, shares will continue to be issued. Long term (ie 6 months plus), funding at this stage is still an issue. There is not much to be gained from consolidation from a shareholder perspective prior to new sales contracts being executed, potentially the only outcome is that the SP could be driven lower. I am hoping that they are very close to getting a contract up and that they expect to announce it prior to the meeting, has now been 3 months since the MOU with the nickel plant so they should be well and truly into the design phase. Feeling de ja vu from 12 months ago here, albeit a little more optimistic than I was this time last year.
- Forums
- ASX - By Stock
- Ann: Notice of General Meeting/Proxy Form
I don't think CR is necessary in the short term, although given...
Featured News
Add VPR (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.07M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $810 | 540K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 39915855 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 67730104 | 44 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
37 | 39915855 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 67730104 | 44 |
0.003 | 31630038 | 28 |
0.004 | 32131341 | 18 |
0.005 | 22975642 | 9 |
0.006 | 33329999 | 5 |
Last trade - 10.45am 03/07/2024 (20 minute delay) ? |
Featured News
VPR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online